Allogene Therapeutics, Inc. (ALLO)

NMS – Real vaqt narxi. Valyuta: USD

2.09

-0.03 (-1.42%)

Bozor ochiq: Aug 12, 2026, 2:52 PM EDT

2.15

+0.03 (1.42%)

Oldingi bozordan keyin: Aug 11, 2026, 7:51 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

04.08.2026

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced that it will report second quarter 2026 financial results and provide a business update on August 12, 2026, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET.

Videolar

No Data

There is no data to display

Allogene Therapeutics, Inc. (ALLO)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Videolar

No Data

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Videolar

No Data

Search stocks

Allogene Therapeutics, Inc. (ALLO)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Videolar

No Data

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Videolar

No Data